Please assess the completion status of the following clinical trial:

Trial Title: Simvastatin in the Prevention of Recurrent Pancreatitis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Adult (\>=18) patients~2. At least 2 episodes of acute pancreatitis or acute flares of chronic pancreatitis~3. Written consent to participate in the study~Exclusion Criteria:~1. \<2 episodes of pancreatitis in the last 12 months.~2. Statin consumption in the previous year.~3. Contraindications to the use of Statins~4. Cholelithiasis or choledocholitiasis diagnosed in the last episode of pancreatitis~5. Endoscopic sphyncterotomy and/or cholecystectomy and/or pancreatic surgery between last episode of AP and recruitment or patients who are expected to undergo one of this techniques in less than a year.~6. Serum triglycerides \>500 mg/dL without previous specific treatment before the last episode of pancreatitis, or in patients expected to have a change in their specific hypertriglyceridemia treatment in less than 1 year~7. Primary hyperparathyroidism that has been operated between last episode of pancreatitis and recruitment or will be operated in less than 1 year~8. Iatrogenic Pancreatitis~9. Abstinence syndrome due to alcohol or drugs and/or delirium tremens in the last 6 months before recruitment~10. Previous (last year) failure to attend follow-up medical visits, social problems that may be associated to failure to take the medication or to perform an adequate follow-up~11. Pregnancy, breastfeeding

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Placebo (Type: PLACEBO_COMPARATOR): placebo~1 year
- Simvastatin (Type: EXPERIMENTAL): 40 mg~1 year

Based on this trial design, predict the completion outcome and termination type (if applicable).